End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
64,500 VND | -0.92% | -6.93% | +13.96% |
Business Summary
Number of employees: 1,411
Sales per Business
VND in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 1,676,312 | 100.0 % | 1,994,037 | 100.0 % | +18.95% |
Sales per region
VND in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Vietnam
100.0
%
| 1,643,707 | 100.0 % | 1,994,037 | 100.0 % | +21.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dao Thi Tran
CEO | Chief Executive Officer | 71 | 83-12-31 |
Dinh Quoc Nguyen
CHM | Chairman | 61 | 98-12-31 |
Tuan Minh Ngo
BRD | Director/Board Member | 45 | 03-12-31 |
Director/Board Member | 44 | 16-12-31 | |
Investor Relations Contact | 41 | 08-09-30 | |
Hanh Hoai Tran
AUD | Comptroller/Controller/Auditor | 61 | 97-06-30 |
Nhung Van Huynh
PRN | Corporate Officer/Principal | 51 | 98-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dao Thi Tran
CEO | Chief Executive Officer | 71 | 83-12-31 |
Dinh Quoc Nguyen
CHM | Chairman | 61 | 98-12-31 |
Director/Board Member | 44 | 16-12-31 | |
Tuan Anh Tran
BRD | Director/Board Member | 51 | 09-04-09 |
Nhung Van Huynh
PRN | Corporate Officer/Principal | 51 | 98-07-31 |
Tuan Minh Ngo
BRD | Director/Board Member | 45 | 03-12-31 |
Director/Board Member | 48 | 18-04-27 | |
Hung Minh Truong
BRD | Director/Board Member | - | 20-05-29 |
Duc Tuan Nguyen
CHM | Chairman | 42 | 08-12-31 |
Kim Chung Le Thi
BRD | Director/Board Member | 64 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 70,038,449 | 8,071,853 ( 11.52 %) | 33,800 ( 0.0483 %) | 11.52 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.96% | 178M | |
+25.78% | 661B | |
+26.74% | 566B | |
-6.65% | 352B | |
+18.99% | 332B | |
+3.17% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.14% | 145B |
- Stock Market
- Equities
- IMP Stock
- Company Imexpharm Corporation